1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow F2G Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olorofim Aspergillus Infection Study Olorofim, AmBisome® - Invasive Aspergillosis | Phase 3 | Completed | F2G Ltd | 225 | 2022-04-29 | 2026-10-08 |
Invasive Fungal Infections (1)
liposomal amphotericin B (1) · olorofim (1)
Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · China (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · New Zealand (1) · Singapore (1) · South Korea (1) · Spain (1)